Osteoporosis treatment may also benefit breast cancer patients

2 octubre 2014

Treatment approaches to reduce the risk of bone metastasis associated with breast cancer may be one step closer to becoming a reality. According to a study, findings show that medication used to treat bone deterioration in post-menopausal women may also slow skeletal metastasis caused from breast cancer. This study is among the first to link bisphosphonate use with improved survival in women with breast cancer.